Shili Ge

机构：Guangdong University of Foreign Studies

发表论文 101 篇 · 总被引 1689 次 · h-index 18

代表论文

• T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals (2021 · Cellular and Molecular Immunology · 被引 91)
• Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia (2020 · Clinical Infectious Diseases · 被引 89)
• Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts (2022 · Kidney International Reports · 被引 59)
• Clazakizumab for desensitization in highly sensitized patients awaiting transplantation (2021 · American Journal of Transplantation · 被引 49)
• CLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962) (2020 · Transplantation · 被引 7)
• CLAZAKIZUMAB (ANTI-IL-6) INDUCES FOXP3+ TREGS IN HIGHLY HLA SENSITIZED PATIENTS RECEIVING HLAI KIDNEY TRANSPLANTATION (NCT03380962) (2020 · Transplantation · 被引 6)